Cumberland Pharmaceuticals CPIX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's total liabilities & equity?
- Cumberland Pharmaceuticals (CPIX) reported total liabilities & equity of $71M in Q1 2026.
- How has Cumberland Pharmaceuticals's total liabilities & equity changed year-over-year?
- Cumberland Pharmaceuticals's total liabilities & equity increased by 1.5% year-over-year, from $69.94M to $71M.
- What is the long-term trend for Cumberland Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's total liabilities & equity has grown at a -4.5% compound annual growth rate (CAGR), from $96.46M to $76.82M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.